New Science and Future Healthcare

Thursday, 04.10.2012 | 18:00 - 19:30 | Congress Centre 1

Sponsored by EFPIA in collaboration with Innovative Medicines Initiative (IMI)

Connecting new science, research and healthcare needs: is the contract between society and pharmaceutical industry up for renewal?

Science is changing! New ways of collaborating in scientific research are revolutionising results and outcomes. New findings are leading to a reclassification of diseases which is consequently changing the way patients are treated and healthcare is delivered. However, are healthcare systems flexible and versatile enough to adapt to new scientific findings? Is society ready for a new science paradigm? Is the contract between society and pharmaceutical industry up for renewal?

This session will seek stakeholders’ views on:

  • how to translate research and science into concrete benefits for patients
  • how the industry and society can develop common agendas towards a new model that links knowledge to adequate patient access
  • how will pressured healthcare systems respond to new evidence and treatments


C Longson, Director, Centre for Health Technology Evaluation, NICE, UK

M Goldman, Executive Director, Innovative Medicines Initiative

S Marschang, Policy Coordinator for Health Systems, European Public Health Alliance

J Attridge, Research Fellow, Imperial College, UK

P Andersen, Senior Vice President, Global Public A_airs and Corporate Patents and Trademarks, H Lundbeck A/S, Denmark

Moderated by

T Jones, Director, Allergan INC

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria